Latest News

Wondering if HCA Healthcare at around US$428.79 is still offering value, or if most of the opportunity is already reflected in the price. The stock has seen a 9.1% decline over the last 30 days and is down 8.8% year to date, yet it has delivered a 21.0% return over 1 year and 116.3% over 5 years. Recent coverage has focused on how a large hospital operator like HCA Healthcare fits into investors' views on healthcare spending and hospital capacity. There has been attention on how its scale...

In recent trading, Singapore-listed Golden Agri-Resources gained attention as higher crude palm oil prices, supported by accelerated biodiesel mandates in Southeast Asia, lifted revenues for plantation operators despite broader market caution amid US-Iran tensions in Gulf waters. An interesting angle is that Golden Agri-Resources’ integrated model means the same palm oil price strength that supports upstream revenue can compress downstream margins through higher feedstock costs and existing...

Sportradar Group AG recently reported first-quarter 2026 sales of €346.52 million with a net loss of €6.29 million, completed a US$228 million share repurchase program covering 12,500,000 shares, and earlier alleged misconduct has prompted multiple law firms to investigate its disclosures and relationships with unlicensed gambling operators. Against this backdrop, the company has appointed former Entain executive Sameer Deen as Chief Operating Officer, signaling a focus on tightening...

Earnings, dividend and buyback update shape NewMarket’s latest move NewMarket (NEU) has put several key pieces on the table at once by reporting first quarter results, declaring a US$3.00 per share dividend, and updating investors on recent share repurchases. See our latest analysis for NewMarket. Those earnings, dividend and buyback updates come after a mixed stretch in the stock, with a 1 month share price return of 8.14% and a 90 day share price return of 4.11%. The 5 year total...

Ellington Financial Inc. has reported past first-quarter 2026 results, posting net income of US$105.32 million and basic and diluted earnings per share from continuing operations of US$0.78. This outcome compared with pre-announcement expectations for earnings per share of US$0.49, highlighting materially stronger profitability than analysts had anticipated. With earnings per share comfortably above prior forecasts, we’ll now examine how this surprise shapes Ellington Financial’s broader...

Wondering whether Harrow at US$40.50 still offers value, or if most of the opportunity is already priced in? This article is built to help you frame that question clearly. The stock has returned 14.7% over the past 30 days, sits on a 67.9% return over 1 year, but is still down 18.9% year to date. This raises fair questions about both upside potential and risk. Recent coverage has focused on Harrow's position in the pharmaceuticals space and how investors are reacting to its latest...

For investors wondering whether Canadian Utilities at around $48.91 still offers value, or if most of the opportunity is already priced in, this article focuses squarely on what the current valuation is indicating. The stock has returned 0.3% over the last 7 days, 14.3% year to date and 33.5% over 1 year, with a 1.5% decline over 30 days providing a small reset in sentiment. Recent headlines around Canadian Utilities have highlighted the company as a long term, income focused utility stock...

Q1 2026 earnings snapshot L.B. Foster (FSTR) opened 2026 with Q1 revenue of US$121.1 million and basic EPS of US$0.15, alongside net income of US$1.5 million, setting a measured tone for the latest earnings season update. Over the past year, the company has seen revenue move from US$504.2 million on a trailing twelve month basis to US$563.4 million, while trailing EPS shifted from US$3.41 to US$1.08, giving investors a mixed picture as they assess how much of the recent margin pressure is...

The market shrugged off Sagtec Global Limited's ( NASDAQ:SAGT ) solid earnings report. Our analysis showed that there...

Accent Group recently warned that its second-half FY26 EBIT would fall well below earlier guidance amid weaker consumer sentiment, higher fuel costs and geopolitical pressures on sales and margins. The company also disclosed it is cooperating with an ASIC investigation into executive share trading while launching a fresh cost-reduction program intended to improve profitability from FY27. We’ll now examine how the downgraded EBIT guidance and new cost-out program reshape Accent Group’s...

We feel now is a pretty good time to analyse Cambria Gold Mines Inc.'s ( CVE:CAMB ) business as it appears the company...

Drilling results and exploration plans move into focus Genesis Minerals (ASX:GMD) is back on watch after high grade drill results at its Leonora operations and a larger exploration budget for FY2026 put its growth plans under a brighter spotlight. See our latest analysis for Genesis Minerals. The latest high grade drill results and larger FY2026 exploration budget come after a mixed period for the stock, with a 1 day share price return of 0.85%, a year to date share price decline of 19.18%, a...

Latest results set the stage for Lindblad Expeditions Holdings (LIND) narrative check Lindblad Expeditions Holdings (LIND) has just opened Q1 2026 earnings season with recent quarterly revenue between US$167.9 million and US$240.2 million and EPS fluctuating from a small loss of US$0.0008 per share to a deeper quarterly loss of US$0.48 over the past year, capped by trailing twelve month EPS of US$0.63 in losses on US$771.0 million of revenue. Over that same stretch, net income moved between a...

If you are wondering whether Denison Mines stock still offers value after a strong run, this article walks through what the current price might be implying. The share price last closed at C$4.90, with returns of 18.4% year to date and 141.4% over the past year, following earlier multi year returns of 222.4% over 3 years and 255.1% over 5 years. Recent coverage around uranium and nuclear energy infrastructure has kept investor attention on producers and developers, adding context to the way...

If you are wondering whether T. Rowe Price Group at around US$104 a share offers fair value or a potential bargain, this article walks through the key numbers so you can judge it for yourself. The stock has returned 3.3% over the last week and 15.5% over the last 30 days, while the 1-year return sits at 21.7% and the 5-year return at a 29.2% decline. This can raise questions about how the current price lines up with fundamentals. Recent coverage has focused on how T. Rowe Price Group is...

Investors may be wondering whether American International Group at around US$78 still offers value or if most of the opportunity is already priced in. The stock recently closed at US$78.47, with returns of 5.8% over 7 days and 4.0% over 30 days. Year to date it shows a 6.9% decline and a 2.8% decline over 1 year, compared with gains of 57.9% over 3 years and 74.4% over 5 years. Recent news has highlighted ongoing interest in large insurers as investors reassess sector risk and capital...

Ribbon Communications Inc.'s ( NASDAQ:RBBN ) robust recent earnings didn't do much to move the stock. We think this is...

WSFS Financial (WSFS) has kicked off Q1 2026 with total revenue of US$277.2 million and basic EPS of US$1.64, backed by net income of US$86.8 million. Over recent quarters, revenue has moved from US$238.8 million and EPS of US$1.13 in Q1 2025 to US$259.2 million and EPS of US$1.34 in Q4 2025, before reaching the latest Q1 2026 levels. With a net interest margin of 3.83% and trailing net profit margins previously characterized as improving, this set of results gives investors a clear,...

Wondering if Volkswagen at €84.36 is a value opportunity or a value trap? This article walks through the numbers so you can judge the price tag with more confidence. The stock has seen pressure recently, with a 2.6% decline over the last week, 3.4% over the last month, 20.8% year to date and 6.4% over the last year, on top of a 17.4% three year and 37.2% five year decline. Recent headlines have focused on how legacy auto companies are repositioning around electric vehicles, software and...

AbbVie (NYSE:ABBV) is expanding access to SKYRIZI for ulcerative colitis patients in Canada through new formulary listings and positive reimbursement recommendations. The company is presenting new clinical outcome data for SKYRIZI and RINVOQ in inflammatory bowel diseases. AbbVie is extending the commercial and clinical reach of its immunology portfolio while pursuing digital transformation efforts in life sciences. For investors watching NYSE:ABBV, these updates highlight fresh activity in...

Investors were disappointed with Sonoco Products Company's ( NYSE:SON ) earnings, despite the strong profit numbers. We...

Just because a business does not make any money, does not mean that the stock will go down. Indeed, Precipitate Gold...

The United States market has seen a robust performance recently, climbing 1.8% in the last week and 30% over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying small-cap stocks that are perceived as undervalued and have insider buying can provide unique opportunities for investors seeking potential growth.

The United States market has shown robust performance, climbing 1.8% in the last week and achieving a 30% increase over the past year, with earnings expected to grow by 16% annually. In this thriving environment, identifying stocks that are priced below their intrinsic value can offer investors opportunities for potential gains while maintaining a focus on fundamental strengths and growth prospects.